Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Clinical trial NCT00823901 · COMPLETED
Trial details
- NCT number
- NCT00823901
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2010-10-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.